Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer
NCT ID: NCT03712774
Last Updated: 2018-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2018-10-12
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quality-of-Life Assessment of Patients Who Have Cancer of the Esophagus
NCT00003321
A Multicenter, Cross-sectional Study on the Quality of Life in Long-term Survival Esophageal Cancer Patients After Radical Radiochemotherapy/Radiotherapy
NCT05828875
Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy
NCT04019548
Chemoradiation and Panitumumab for Esophageal Cancer
NCT01077999
Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial
NCT00907543
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
neoadjuvant chemoradiation
Patient with esophageal Cancer treated by neoadjuvant chemoradiation followed by surgery will be longitudinally evaluated by questionaires EORTC QLQ C30, EORTC QLQ OES-18 and EORTC OG-25
EORTC QLQ C30
standardized questionaire
EORTC QLQ OES-18
standardized questionaire
EORTC OG-25
standardized questionaire
definitive chemoradiation
Patient with esophageal Cancer treated by definitive chemoradiation will be longitudinally evaluated by questionaires EORTC QLQ C30, EORTC QLQ OES-18 and EORTC OG-25
EORTC QLQ C30
standardized questionaire
EORTC QLQ OES-18
standardized questionaire
EORTC OG-25
standardized questionaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EORTC QLQ C30
standardized questionaire
EORTC QLQ OES-18
standardized questionaire
EORTC OG-25
standardized questionaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* indication for neoadjuvant or definitive chemoradiation using either cisplatin/5-FU or carboplatin/paclitaxel with curative intent
* age \>= 18 years
* written informed consent
* ability to answer the standardized questionaires according to the treating physician
Exclusion Criteria
* Treatment with palliative intent
* distant metastases (except supraclavicular nodes)
* second malignancy
* Prior systemic treatment for esophageal Cancer
* Treatment in an interventional study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig-Maximilians - University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Falk Roeder
Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Falk Roeder, MD
Role: PRINCIPAL_INVESTIGATOR
Ludwig-Maximilians Universität München
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Radiation Oncology, University Hospital, LMU Munich
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V1 08_2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.